248 related articles for article (PubMed ID: 18270971)
1. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
3. Growth patterns of osteosarcoma predict patient survival.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
[TBL] [Abstract][Full Text] [Related]
4. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations.
Cho WH; Song WS; Jeon DG; Kong CB; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
Ann Surg Oncol; 2010 Mar; 17(3):702-8. PubMed ID: 19921336
[TBL] [Abstract][Full Text] [Related]
5. time dependency of prognostic factors in patients with stage II osteosarcomas.
Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Oct; 463():157-65. PubMed ID: 17621233
[TBL] [Abstract][Full Text] [Related]
6. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
7. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
[TBL] [Abstract][Full Text] [Related]
8. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma.
Reddick WE; Wang S; Xiong X; Glass JO; Wu S; Kaste SC; Pratt CB; Meyer WH; Fletcher BD
Cancer; 2001 Jun; 91(12):2230-7. PubMed ID: 11413510
[TBL] [Abstract][Full Text] [Related]
9. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].
Rehan N; Bieling P; Winkler P; Helmke K; Maas R; Baldini N; Heise U; Fuchs N; Winkler K
Klin Padiatr; 1993; 205(4):200-9. PubMed ID: 8377444
[TBL] [Abstract][Full Text] [Related]
12. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of increased angiogenesis in osteosarcoma.
Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients.
Laskar S; Basu A; Muckaden MA; D'Cruz A; Pai S; Jambhekar N; Tike P; Shrivastava SK
Head Neck; 2008 Aug; 30(8):1020-6. PubMed ID: 18383528
[TBL] [Abstract][Full Text] [Related]
16. An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
J Surg Oncol; 2008 Nov; 98(6):427-31. PubMed ID: 18683209
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma developed in the period of maximal growth rate have inferior prognosis.
Lee JA; Kim MS; Kim DH; Lim JS; Park KD; Song WS; Lee SY; Jeon DG
J Pediatr Hematol Oncol; 2008 Jun; 30(6):419-24. PubMed ID: 18525457
[TBL] [Abstract][Full Text] [Related]
18. National Cancer Data Base report on osteosarcoma of the head and neck.
Smith RB; Apostolakis LW; Karnell LH; Koch BB; Robinson RA; Zhen W; Menck HR; Hoffman HT
Cancer; 2003 Oct; 98(8):1670-80. PubMed ID: 14534884
[TBL] [Abstract][Full Text] [Related]
19. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
20. Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity.
Kaste SC; Liu T; Billups CA; Daw NC; Pratt CB; Meyer WH
Pediatr Blood Cancer; 2004 Dec; 43(7):723-8. PubMed ID: 15390310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]